UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
FDA OKs Huons' generic of topic anesthetic injection
Huons said that the U.S. Food and Drug Administration has approved the comp...
by Lee Han-soo
|
2020-01-02 14:30
라인
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market
Medytox said that the Ministry of Food and Drug Safety has approved to sell...
by Lee Han-soo
|
2020-01-02 12:12
라인
Medical info kiosk lends a helping hand for foreign patients
It's not easy navigating a foreign city even if the purpose of the visi...
by Lee Han-soo
|
2020-01-01 05:27
라인
MSD’s monitoring causes stir for alleged violation of physicians’ privacies
For MSD Korea, 2019 was an embarrassing year.The company’s self-assurance p...
by Kim Yun-mi
|
2019-12-31 12:40
라인
Allergan shrouded in controversy for rare cancer-causing breast implants
Allergan caused a hot controversy this year after worries that its artifici...
by Park Gi-taek
|
2019-12-31 10:20
라인
Korea Biomedical Review’s ‘Top 20’ news
By most accounts, 2019 was another memorable year for Korea’s medical and b...
by Lee Han-soo
|
2019-12-31 10:17
라인
Korean biopharmaceuticals competitively move abroad to expand global presence
Local pharmaceutical companies are actively advancing to overseas markets. ...
by Jeong Sae-im
|
2019-12-30 17:20
라인
Industry welcomes legislation of advanced regenerative bio act
The National Assembly finally passed the "Act on Safety and Support for Adv...
by Park Gi-taek
|
2019-12-30 11:56
라인
Shanghai Ocumension to market Huonland's HA eyedrop
Huonland, a joint venture between Huons and Beijing Northland, said that it...
by Lee Han-soo
|
2019-12-23 15:43
라인
Alteogen's growth hormone deficiency treatment wins orphan drug status
Alteogen said that the U.S. Food and Drug Administration has granted an orp...
by Lee Han-soo
|
2019-12-23 14:46
라인
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market
Daewoong Pharmaceutical said that it has agreed with Aeon Biopharma to expa...
by Lee Han-soo
|
2019-12-23 11:23
라인
SNUBH teaches cerebrovascular surgery tech to Thai hospital
Seoul National University Bundang Hospital (SNUBH) said Professors Bang Jae...
by Lee Han-soo
|
2019-12-20 17:37
라인
‘Depressed cancer patients have higher risk of death’
Researchers at Seoul National University Hospital have found that depressio...
by Lee Han-soo
|
2019-12-20 16:30
라인
Successful drug development – getting it right from the start
When it comes to successful drug development, today’s pharma and biotech co...
by Lee Han-soo
|
2019-12-20 16:30
라인
Samsung Bioepis’ Ontruzant 1st biosimilar to win WHO's PQ certification
Samsung Bioepis announced that Ontruzant, a trastuzumab biosimilar (Origina...
by Lee Han-soo
|
2019-12-20 16:29
라인
Chemas to research anticancer treatment in Germany
Chemas, a local pharmaceutical company, said that it has completed its prep...
by Lee Han-soo
|
2019-12-20 15:18
라인
Bridge Biotherapeutics seeks IND status for lung cancer treatment
Bridge Biotherapeutics said it has filed an investigational new drug (IND) ...
by Lee Han-soo
|
2019-12-20 14:41
라인
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate
Boehringer Ingelheim said that it has decided to discontinue its developmen...
by Lee Han-soo
|
2019-12-19 17:42
라인
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation
AstraZeneca said that it has signed a memorandum of understanding with four...
by Lee Han-soo
|
2019-12-19 17:40
라인
AstraZeneca, SK Holdings celebrates manufacturing partnership
AstraZeneca and SK Holdings said they have reached an important milestone i...
by Lee Han-soo
|
2019-12-19 16:39
-
이전
21
22
23
24
25
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top